Cargando…
Frequency and Outcomes of Ipsilateral Axillary Lymphadenopathy After COVID-19 Vaccination
This case series reports on the frequency and outcomes of breast imaging–identified ipsilateral axillary lymphadenopathy after recent COVID-19 vaccination among women.
Autores principales: | Zhou, Wenhui, DeMartini, Wendy B., Ikeda, Debra M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178432/ https://www.ncbi.nlm.nih.gov/pubmed/35675077 http://dx.doi.org/10.1001/jamanetworkopen.2022.16172 |
Ejemplares similares
-
Ipsilateral Lymphadenopathy, COVID-19 Vaccination and Breast Cancer
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
COVID-19 Vaccination and Subclinical Axillary Lymphadenopathy on Mammogram: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
por: Teo, Shyh Poh
Publicado: (2021) -
Axillary Lymphadenopathy After mRNA COVID-19 Vaccination
por: Ahn, Richard W., et al.
Publicado: (2021) -
Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer
por: Adin, Mehmet Emin, et al.
Publicado: (2022)